BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Geschlossen

BrancheImmobilien

33.77 0.12

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

33.42

Max

34.13

Schlüsselkennzahlen

By Trading Economics

Einkommen

224M

377M

Verkäufe

329M

1.3B

KGV

Branchendurchschnitt

56.712

58.706

EPS

0.26

Dividendenrendite

1.15

Gewinnspanne

29.462

Angestellte

7,384

EBITDA

379M

654M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+13.45% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.15%

5.81%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.4B

20B

Vorheriger Eröffnungskurs

33.65

Vorheriger Schlusskurs

33.77

Nachrichtenstimmung

By Acuity

45%

55%

52 / 190 Ranking in Real estate

Fisher & Paykel Healthcare Corp Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Mai 2025, 22:28 UTC

Market Talk

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8. Apr. 2025, 02:01 UTC

Market Talk

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3. Feb. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2. Feb. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28. Nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18. Nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2. Sept. 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

Peer-Vergleich

Kursveränderung

Fisher & Paykel Healthcare Corp Ltd Prognose

Kursziel

By TipRanks

13.45% Vorteil

12-Monats-Prognose

Durchschnitt 38.347 AUD  13.45%

Hoch 42.1 AUD

Tief 35.9 AUD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fisher & Paykel Healthcare Corp Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

5

Buy

4

Halten

0

Sell

Stimmung

By Acuity

52 / 190 Ranking in Immobilien

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.